Year Book of Pulmonary Disease

Name: Year Book of Pulmonary Disease
Brand: Elsevier
Price: 110.99 EUR
Availability: OnlineOnly

James A. Barker(Autor*in)

Elsevier (Verlag)

1. Auflage

Erschienen am 4. Juni 2015

100 Seiten

E-Book

ePUB mit Adobe-DRM

Systemvoraussetzungen

978-0-323-44233-6 (ISBN)

110,99 €inkl. 7% MwSt.

Systemvoraussetzungen

für ePUB mit Adobe-DRM

E-Book Einzellizenz

Als Download verfügbar

Beschreibung

Weitere Details

Weitere Ausgaben

Inhalt

Cover image
Title page
Table of Contents
1. Asthma, Allergy and Cystic Fibrosis
1.1. Asthma
Trends in the age of diagnosis of childhood asthma
Abstract
Commentary
Asthma: pathogenesis and novel drugs for treatment
Abstract
Commentary
New Risk Factors for Adult-Onset Incident Asthma: A Nested Case-Control Study of Host Antioxidant Defense
Abstract
Commentary
Identification of novel immune phenotypes for allergic and nonallergic childhood asthma
Abstract
Commentary
Management of acute loss of asthma control in the yellow zone: A practice parameter
Abstract
Commentary
A randomized trial of benralizumab, an antiinterleukin 5 receptor a monoclonal antibody, after acute asthma
Abstract
Commentary
The effect of fluticasone furoate/umeclidinium in adult patients with asthma: A randomized, dose-ranging study
Abstract
Commentary
A randomized, three-period crossover study of umeclidinium as monotherapy in adult patients with asthma
Abstract
Commentary
Cluster Analysis and Characterization of Response to Mepolizumab: A Step Closer to Personalized Medicine for Patients with Severe Asthma
Abstract
Commentary
Comprehensive efficacy of omalizumab for severe refractory asthma: a time-series observational study
Abstract
Commentary
Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: A randomised dose-ranging study
Abstract
Commentary
Inhaled corticosteroid beliefs, complementary and alternative medicine, and uncontrolled asthma in urban minority adults
Abstract
Commentary
Impact of exhaled nitric oxide measurements on treatment decisions in an asthma specialty clinic
Abstract
Commentary
Linking Patient-Centered Medical Home and Asthma Measures Reduces Hospital Readmission Rates
Abstract
Commentary
Evolution of occupational asthma: Does cessation of exposure really improve prognosis?
Abstract
Commentary
Comparison of US emergency department acute asthma care quality: 1997-2001 and 2011-2012
Abstract
Commentary
EAACI position paper: irritant-induced asthma
Abstract
Commentary
Rates and Correlates of Relapse Following ED Discharge for Acute Asthma: A Canadian 20-Site Prospective Cohort Study
Abstract
Commentary
Vitamin D, asthma prevalence and asthma exacerbations: a large adult population-based study
Abstract
Commentary
Risk of congenital malformations for asthmatic pregnant women using a long-acting ß2-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy
Abstract
Commentary
PRAM Score as Predictor of Pediatric Asthma Hospitalization
Abstract
Commentary
Comparing the Asthma APGAR System and the Asthma Control TestT in a Multicenter Primary Care Sample
Abstract
Commentary
1.2. Cystic Fibrosis
Gene therapy in cystic fibrosis
Abstract
Commentary
Cystic Fibrosis Foundation Pulmonary Guideline: Pharmacologic Approaches to Prevention and Eradication of Initial Pseudomonas aeruginosa Infection
Abstract
Commentary
Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis
Abstract
Commentary
Longevity of Patients With Cystic Fibrosis in 2000 to 2010 and Beyond: Survival Analysis of the Cystic Fibrosis Foundation Patient Registry
Abstract
Commentary
Medical and obstetric complications among pregnant women with cystic fibrosis
Abstract
Commentary
1.3. Miscellaneous
Scientific Foundations of Allergen-Specific Immunotherapy for Allergic Disease
Abstract
Commentary
2. Chronic Obstructive Pulmonary Disease
The association between childhood asthma and adult chronic obstructive pulmonary disease
Abstract
Commentary
Pneumothorax Risk Factors in Smokers with and without Chronic Obstructive Pulmonary Disease
Abstract
Commentary
Severity-Related Changes of Bronchial Microbiome in Chronic Obstructive Pulmonary Disease
Abstract
Commentary
Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE
Abstract
Commentary
Performance of the BODE index in patients with a1-antitrypsin deficiency-related COPD
Abstract
Commentary
The COPD assessment test: a systematic review
Abstract
Commentary
Physical Activity as a Predictor of Thirty-Day Hospital Readmission after a Discharge for a Clinical Exacerbation of Chronic Obstructive Pulmonary Disease
Abstract
Commentary
Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality
Abstract
Commentary
Efficacy and Safety of a Fixed-Dose Combination of Indacaterol and Glycopyrronium for the Treatment of COPD: A Systematic Review
Abstract
Commentary
Combination Long-Acting ß-Agonists and Inhaled Corticosteroids Compared With Long-Acting ß-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease
Abstract
Commentary
Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
Abstract
Commentary
Predictors of Chronic Obstructive Pulmonary Disease Exacerbation Reduction in Response to Daily Azithromycin Therapy
Abstract
Commentary
Benefits of High-Dose N-Acetylcysteine to Exacerbation-Prone Patients With COPD
Abstract
Commentary
Breathlessness, Functional Status, Distress, and Palliative Care Needs Over Time in Patients With Advanced Chronic Obstructive Pulmonary Disease or Lung Cancer: A Cohort Study
Abstract
Commentary
3. Lung cancer
3.1. Epidemiology of Lung Cancer
Cancer Statistics, 2014
Abstract
Commentary
Is Previous Respiratory Disease a Risk Factor for Lung Cancer?
Abstract
Commentary
Radiation Risks in Lung Cancer Screening Programs: A Comparison With Nuclear Industry Workers and Atomic Bomb Survivors
Abstract
Commentary
3.2. Tobacco-related Issues
Global Effects of Smoking, of Quitting, and of Taxing Tobacco
Abstract
Commentary
Estimation of Cigarette Smoking-Attributable Morbidity in the United States
Abstract
Commentary
Electronic Cigarettes: A Position Statement of the Forum of International Respiratory Societies
Abstract
Commentary
Hidden Formaldehyde in E-Cigarette Aerosols
Abstract
Commentary
3.3. Lung cancer Screening
Components Necessary for High Quality Lung Cancer Screening: American College of Chest Physicians and American Thoracic Society Policy Statement
Abstract
Commentary
Cost-Effectiveness of CT Screening in the National Lung Screening Trial
Abstract
Commentary
CT Screening for Lung Cancer: Alternative Definitions of Positive Test Result Based on the National Lung Screening Trial and International Early Lung Cancer Action Program Databases
Abstract
Commentary
Lung Cancer Screening
Abstract
Commentary
Cancer Screening in the United States, 2014: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening
Abstract
Commentary
Chest CT Scan Screening for Lung Cancer in Asbestos Occupational Exposure: A Systematic Review and Meta-analysis
Abstract
Commentary
3.4. Diagnostic Evaluation
The Utility of Nodule Volume in the Context of Malignancy Prediction for Small Pulmonary Nodules
Abstract
Commentary
How many names for a rose: Inconsistent classification of multiple foci of lung cancer due to ambiguous rules
Abstract
Commentary
Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Non-Small Cell Lung Cancer Staging
Abstract
Commentary
Cost effectiveness of endosonography versus surgical staging in potentially resectable lung cancer: a health economics analysis of the ASTER trial from a European perspective
Abstract
Commentary
Accuracy of FDG-PET to Diagnose Lung Cancer in Areas With Infectious Lung Disease: A Meta-analysis
Abstract
Commentary
Assessing the Usefulness of 18F-fluorodeoxyglucose PET-CT Scan After Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer
Abstract
Commentary
3.5. Lung Cancer Treatment
Appropriate Sublobar Resection Choice for Ground Glass Opacity-Dominant Clinical Stage IA Lung Adenocarcinoma: Wedge Resection or Segmentectomy
Abstract
Commentary
Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules
Abstract
Commentary
3.6. Molecular Approach to Lung Cancer
Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Society for the Study of Lung Cancer/Association of Molecular Pathologists Guideline
Abstract
Commentary
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Abstract
Commentary
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Abstract
Commentary
Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
Abstract
Commentary
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
Abstract
Commentary
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
Abstract
Commentary
4. Pleural, Interstitial Lung, and Pulmonary Vascular Disease
4.1. Interstitial Lung Disease
Relationship of DNA Methylation and Gene Expression in Idiopathic Pulmonary Fibrosis
Abstract
Commentary
Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis
Abstract
Commentary
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Abstract
Commentary
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Abstract
Commentary
4.2. Pleural Disease
Comparison of Pleural Pressure Measuring Instruments
Abstract
Commentary
Pleural Plaques and Their Effect on Lung Function in Libby Vermiculite Miners
Abstract
Commentary
Comparing Cost of Indwelling Pleural Catheter vs Talc Pleurodesis for Malignant Pleural Effusion
Abstract
Commentary
4.3. Pulmonary Vascular Disease
The Right Ventricle Explains Sex Differences in Survival in Idiopathic Pulmonary Arterial Hypertension
Abstract
Commentary
Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults: CHEST Guideline and Expert Panel Report
Abstract
Commentary
Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism
Abstract
Commentary
5. Community-Acquired Pneumonia
Rates and Risk Factors for Recurrent Pneumonia in Patients Hospitalized With Community-Acquired Pneumonia: Population-Based Prospective Cohort Study With 5 Years of Follow-up
Abstract
Commentary
Diagnoses of Early and Late Readmissions after Hospitalization for Pneumonia: A Systematic Review
Abstract
Commentary
Characteristics and Outcomes of Patients Hospitalized Following Pulmonary Aspiration
Abstract
Commentary
Predictive Value of Testing Nasopharyngeal Samples for Respiratory Viruses in the Setting of Lower Respiratory Tract Disease
Abstract
Commentary
Lower Respiratory Tract Virus Findings in Mechanically Ventilated Patients With Severe Community-Acquired Pneumonia
Abstract
Commentary
Bacteremia prediction model using a common clinical test in patients with community-acquired pneumonia
Abstract
Commentary
Invasive Pneumococcal Disease After Implementation of 13-Valent Conjugate Vaccine
Abstract
Commentary
Emergence of Hypervirulent Mutants Resistant to Early Clearance During Systemic Serotype 1 Pneumococcal Infection in Mice and Humans
Abstract
Commentary
Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia
Abstract
Commentary
Platelet Activation Is Associated With Myocardial Infarction in Patients With Pneumonia
Abstract
Commentary
A 16-Year Prospective Study of Community-Onset Bacteremic Acinetobacter Pneumonia: Low Mortality With Appropriate Initial Empirical Antibiotic Protocols
Abstract
Commentary
Community-acquired lung respiratory infections in HIV-infected patients: microbial aetiology and outcome
Abstract
Commentary
Legionellosis and biologic therapies
Abstract
Commentary
Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium Avium Complex Lung Disease
Abstract
Commentary
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
Abstract
Commentary
Vaccination Against Staphylococcus aureus Pneumonia
Abstract
Commentary
6. Lung Transplantation
Use of the Donor Lung After Asphyxiation or Drowning: Effect on Lung Transplant Recipients
Abstract
Commentary
Assessment of Different Threshold Preoperative Glomerular Filtration Rates as Markers of Outcomes in Lung Transplantation
Abstract
Commentary
Body Mass Index in Lung Transplant Candidates: A Contra-indication to Transplant or Not?
Abstract
Commentary
Pre-transplant donor HLA-specific antibodies: Characteristics causing detrimental effects on survival after lung transplantation
Abstract
Commentary
Genetic Variation in Caveolin-1 Affects Survival After Lung Transplantation
Abstract
Commentary
Characteristics of Patients with Pulmonary Venoocclusive Disease Awaiting Transplantation
Abstract
Commentary
Alemtuzumab in Lung Transplantation: An Open-Label, Randomized, Prospective Single Center Study
Abstract
Commentary
Air Pollution and the Development of Posttransplant Chronic Lung Allograft Dysfunction
Abstract
Commentary
Loss of glucocorticoid receptor from pro-inflammatory T cells after lung transplant
Abstract
Commentary
Azithromycin and the Treatment of Lymphocytic Airway Inflammation After Lung Transplantation
Abstract
Commentary
High CXCL-16 Levels Correlate With Symptomatic Disease in Lung Transplant Recipients With Human Cytomegalovirus Replication in the Allograft
Abstract
Commentary
Characteristics and Outcomes of Patients With Lung Transplantation Requiring Admission to the Medical ICU
Abstract
Commentary
Diverticulitis occurs early after lung transplantation
Abstract
Commentary
Morbidity and Mortality of Live Lung Donation: Results From the RELIVE Study
Abstract
Commentary
7. Sleep Disorders
7.1. Consequences of Sleep-Disordered Breathing
Obstructive Sleep Apnea and Severe Maternal-Infant Morbidity/Mortality in the United States, 1998-2009
Abstract
Commentary
Role of Sleep Apnea and Continuous Positive Airway Pressure Therapy in the Incidence of Stroke or Coronary Heart Disease in Women
Abstract
Commentary
Nocturnal intermittent hypoxia predicts prevalent hypertension in the European Sleep Apnoea Database cohort study
Abstract
Commentary
Diabetes Mellitus Prevalence and Control in Sleep-Disordered Breathing: The European Sleep Apnea Cohort (ESADA) Study
Abstract
Commentary
7.2. Non-CPAP Treatment of Sleep-Disordered Breathing
The Complex Sleep Apnea Resolution Study: A Prospective Randomized Controlled Trial of Continuous Positive Airway Pressure Versus Adaptive Servoventilation Therapy
Abstract
Commentary
Tongue Fat and its Relationship to Obstructive Sleep Apnea
Abstract
Commentary
7.3. Non-Pulmonary Sleep
Sleep Restriction Therapy for Insomnia is Associated with Reduced Objective Total Sleep Time, Increased Daytime Somnolence, and Objectively Impaired Vigilance: Implications for the Clinical Management of Insomnia Disorder
Abstract
Commentary
Actigraphy-Measured Sleep Disruption as a Predictor of Survival among Women with Advanced Breast Cancer
Abstract
Commentary
Rapid Eye Movement Sleep Behavioral Events: A New Marker for Neurodegeneration in Early Parkinson Disease?
Abstract
Commentary
Insufficient Sleep in Adolescents and Young Adults: An Update on Causes and Consequences
Abstract
Commentary
Subjective and Objective Sleep Disturbance and Longitudinal Risk of Depression in a Cohort of Older Women
Abstract
Commentary
Risk of Sleep Apnea in Hospitalized Older Patients
Abstract
Commentary
A Randomized Controlled Trial of Mindfulness Meditation for Chronic Insomnia
Abstract
Commentary
A Randomized, Double Crossover Study to Investigate the Influence of Saline Infusion on Sleep Apnea Severity in Men
Abstract
Commentary
7.4. Pediatric Sleep-Disordered Breathing
Predictors of Obstructive Sleep Apnea Severity in Adenotonsillectomy Candidates
Abstract
Commentary
8. Critical Care Medicine
8.1. Sepsis
Preparing an ICU room to welcome a critically ill patient with Ebola virus disease
Abstract
Commentary
Diagnostic Characteristics of a Clinical Screening Tool in Combination With Measuring Bedside Lactate Level in Emergency Department Patients With Suspected Sepsis
Abstract
Commentary
Bleeding complications of central venous catheterization in septic patients with abnormal hemostasis
Abstract
Commentary
Cholecystostomy offers no survival benefit in patients with acute acalculous cholecystitis and severe sepsis and shock
Abstract
Commentary
Early intensive care unit-acquired hypernatremia in severe sepsis patients receiving 0.9% saline fluid resuscitation
Abstract
Commentary
Early Management of Severe Sepsis: Concepts and Controversies
Abstract
Commentary
8.2. Airway
Angular change in the line of vision to the larynx: implications for determining the laryngoscopic view
Abstract
Commentary
Difficult Airway Management for Novice Physicians: A Randomized Trial Comparing Direct and Video-Assisted Laryngoscopy
Abstract
Commentary
8.3. Acute Respiratory Disorder Syndrome
Acute respiratory distress attributed to sirolimus in solid organ transplant recipients
Abstract
Commentary
8.4. Acute Respiratory Failure
A 42-Year-Old Farmer From Bangladesh With Respiratory Failure, Septic Arthritis, and Multiple Cavitating Consolidations
Abstract
Commentary
8.5. Acute Lung Injury
A Quality Improvement Project Sustainably Decreased Time to Onset of Active Physical Therapy Intervention in Patients with Acute Lung Injury
Abstract
Commentary
8.6. Trauma
Association of head, thoracic and abdominal trauma with delayed diagnosis of co-existing injuries in critical trauma patients
Abstract
Commentary
Air Transport of Patients with Pneumothorax: Is Tube Thoracostomy Required Before Flight?
Abstract
Commentary
8.7. Non Invasive Ventilation
Efficacy and Safety of Early Dexmedetomidine During Noninvasive Ventilation for Patients with Acute Respiratory Failure: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
Abstract
Commentary
8.8. Severe Pneumonia
Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: Results from the randomized ProHOSP trial
Abstract
Commentary
8.9. Pulmonary Hypertension
Catheter-Directed Thrombolytic Intervention Is Effective for Patients with Massive and Submassive Pulmonary Embolism
Abstract
Commentary
8.10. Miscellaneous
Critical care responsibility in health care reform: What would Osler say?
Abstract
Commentary
Copper removal strategies for Wilson's disease crisis in the ICU
Abstract
Commentary
A randomised controlled trial comparing incentive spirometry with the Acapella® device for physiotherapy after thoracoscopic lung resection surgery
Abstract
Commentary
Characteristics and Outcomes of Patients Admitted to the Acute Palliative Care Unit From the Emergency Center
Abstract
Commentary
A Health System-Based Critical Care Program with a Novel Tele-ICU: Implementation, Cost, and Structure Details
Abstract
Commentary
Dying with Dignity in the Intensive Care Unit
Abstract
Commentary
Brain Death and Islam: The Interface of Religion, Culture, History, Law, and Modern Medicine
Abstract
Commentary
8.11. Imaging
Double-lung point sign in traumatic pneumothorax
Abstract
Commentary

Systemvoraussetzungen

Als PDF speichern Als Link merken